Anti-inflammatory properties of extracts, fractions and lignans isolated from Phyllanthus amarus

Planta Medica

Volumn 71, Issue 8, 2005, Pages 721-726

  Kassuya, Cândida A L ^a   Leite, Daniela F P ^a   De Melo, Lucilia Vilela ^b   Rehder, Vera Lúcia C ^b   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Anti inflammatory action; Carrageenan; Myeloperoxidase; Paw oedema; Phyllanthus amarus

Indexed keywords

BRADYKININ; CARRAGEENAN; ENDOTHELIN 1; HEXANE; HISTAMINE; HYPOPHYLLANTHIN; INTERLEUKIN 1BETA; LIGNAN DERIVATIVE; NIRANTHIN; NIRTETRALIN; PHYLLANTHIN; PHYLLANTHUS AMARUS EXTRACT; PHYLTETRALIN; SUBSTANCE P; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG ISOLATION; DRUG PURIFICATION; DRUG SYNTHESIS; ENZYME INHIBITION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PAW EDEMA; PHYLLANTHUS AMARUS; SOLVENT EXTRACTION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; LIGNANS; MALE; MICE; PHYLLANTHUS; PHYTOTHERAPY; PLANT EXTRACTS;

PHYLLANTHUS AMARUS;

EID: 24944522851     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-871258     Document Type: Article

References (25)

1. Unander DW, Webster GL, Blumberg BS. Usage and bioassays in Phyllanthus (Euphorbiaceae). IV. Clustering of antiviral uses and other effects. J Ethnopharmacol 1995; 45: 1-18
2. Calixto JB, Santos AR, Cechinel Filho V, Yunes RA. A review of the plants of the genus Phyllanthus: their chemistry, pharmacology, and therapeutic potential. Med Res Rev 1998; 18: 225-58
3. Venkateswaran PS, Millman I, Blumberg BS. Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies. Proc Natl Acad Sci USA 1987; 84: 274-8
4. Wang BE. Treatment of chronic liver diseases with traditional Chinese medicine. J Gastroenterol Hepatol 2000; 15: S67-70
5. Notka F, Meier GR, Wagner R. Inhibition of wild-type human immunodeficiency virus and reverse transcriptase inhibitor-resistant variants by Phyllanthus amarus. Antiviral Res 2003; 58: 175-86
6. Rajeshkumar NV, Kuttan R. Phyllanthus amarus extract administration increases the life span of rats with hepatocellular carcinoma. J Ethnopharmacol 2000; 73: 215-9
7. Raphael KR, Kuttan R. Inhibition of experimental gastric lesion and inflammation by Phyllanthus amarus extract. J Ethnopharmacol 2003; 87: 193-7
8. Kiemer AK, Hartung T, Huber C, Vollmar AM. Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-kappaB pathway. J Hepatol 2003; 38: 289-97
9. Kassuya CAL, Silvestre AA, Rehder VL, Calixto JB. Anti-allodynic and anti-oedematogenic properties of the extract and lignans from Phyllanthus amarus in models of persistent inflammatory and neuropathic pain. Eur J Pharmacol 2003; 478: 145-53
10. Bastos JK, Carvalho JC, de Souza GH, Pedrazzi AH, Sarti SJ. Anti-inflammatory activity of cubebin, a lignan from the leaves of Zanthoxyllum naranjillo Griseb. J Ethnopharmacol 2001; 75: 279-82
11. MacRae WD, Towers GHN. Biological activities of lignans. Phytochemistry 1984; 23: 1207-20
12. Hussain RA, Dickey JJ, Rosser MP, Marson JA, Kozlowski MR. A novel class of non-peptidic endothelin antagonists isolated from the medicinal herb Phyllanthus niruri. J Nat Prod 1995; 58: 1515-20
13. 13C-NMR assignments of phyllanthin and hypophyllanthin: lignans that enhance cytotoxic responses with cultured multidrug-resistant cells. J Nat Prod 1993; 56: 233-9
14. Anjaneyulu ASR, Jaganmohan RK, Ramachandra RL, Subrahmanyan C. Isolation and structural elucidation of tree new lignans from the leaves of Phyllanthus niruri Linn. Tetrahedron 1973; 29: 1291-8
15. Correa CR, Calixto JB. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse. Br J Pharmacol 1993; 110: 193-8
16. De Young LM, Kheifets JB, Ballaron SJ, Young JM. Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents. Agents Actions 1989; 26: 335-41
17. Pinheiro RM, Calixto JB. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. Inflamm Res 2002; 51: 603-10
18. André E, Ferreira J, Malheiros A, Yunes RA, Calixto JB. Evidence for the involvement of vanilloid receptor in the antinociception produced by the dialdeydes unsaturated sesquiterpenes polygodial and drimanial in rats. Neuropharmacology 2004; 46: 590-7
19. Calixto JB, Otuki MF, Santos AR. Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor kappa B (NF-kappaB). Planta Med 2003; 69: 973-83
20. Calixto JB, Campos MM, Otuki MF, Santos AR. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 2004; 70: 93-103
21. Graham MF, Willey A, Zhu YN, Yager DR, Sugerman HJ, Diegelmann RF. Corticosteroids repress the interleukin 1 beta-induced secretion of collagenase in human intestinal smooth muscle cells. Gastroenterology 1997; 113: 1924-9
22. Oluyomi AO, Nguyen H, Towbin H, Dawson J, Vosbeck K. Differential effects of prednisolone and indomethacin on zymosan-induced inflammation in a modified murine tissue-chamber model. Inflamm Res 1995; 44: 350-6
23. Evangelou AM. Platelet-activating factor (PAF): implications for coronary heart and vascular diseases. Prostaglandins Leukot Essent Fatty Acids 1994; 50: 1-28
24. Bertelli A, Clerico A, Chicca A, Giovannini I, Gorio A, Romano MA. Role of endothelin-1 in carrageenan-induced inflammation. Int J Tissue Reactions Exp and Clin Asp 1992; 14: 225-30
25. Lee IS, Jung KY, Oh SR, Park SH, Ahn KS, Lee HK. Structure-activity relationships of lignans from Schisandra chinensis as platelet activating factor antagonists. Biol Pharm Bull 1999; 22: 265-7